Catalyst Pharmaceuticals (CPRX) Finished Goods (2023 - 2025)
Historic Finished Goods for Catalyst Pharmaceuticals (CPRX) over the last 3 years, with Q3 2025 value amounting to $11.3 million.
- Catalyst Pharmaceuticals' Finished Goods rose 2216.81% to $11.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.3 million, marking a year-over-year increase of 2216.81%. This contributed to the annual value of $9.6 million for FY2024, which is 455.19% up from last year.
- As of Q3 2025, Catalyst Pharmaceuticals' Finished Goods stood at $11.3 million, which was up 2216.81% from $8.1 million recorded in Q2 2025.
- Catalyst Pharmaceuticals' Finished Goods' 5-year high stood at $11.3 million during Q3 2025, with a 5-year trough of $8.1 million in Q1 2025.
- Moreover, its 3-year median value for Finished Goods was $9.2 million (2023), whereas its average is $9.1 million.
- Over the last 5 years, Catalyst Pharmaceuticals' Finished Goods had its largest YoY gain of 2216.81% in 2025, and its largest YoY loss of 328.77% in 2025.
- Quarter analysis of 3 years shows Catalyst Pharmaceuticals' Finished Goods stood at $9.2 million in 2023, then increased by 4.55% to $9.6 million in 2024, then increased by 17.9% to $11.3 million in 2025.
- Its Finished Goods was $11.3 million in Q3 2025, compared to $8.1 million in Q2 2025 and $8.1 million in Q1 2025.